Eric Sherman, MD
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Eric Sherman, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:05 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04238624 · Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid CancerMemorial Sloan Kettering Cancer Center · active not recruiting · Anaplastic Thyroid Cancer, Thyroid Cancer, BRAF Gene Mutation · principal investigator
- Early Ph1NCT03085056 · Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid CancerMemorial Sloan Kettering Cancer Center · active not recruiting · Anaplastic Thyroid Cancer · principal investigator
- Ph2NCT01141309 · Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid CancerMemorial Sloan Kettering Cancer Center · active not recruiting · Thyroid Cancer · principal investigator
- Ph2NCT01025453 · Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid CancerMemorial Sloan Kettering Cancer Center · completed · Thyroid Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:05 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.N Engl J Med · 20181,214 citationsRCR 55.6
- Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.Thromb Haemost · 2018168 citationsRCR 7.1
- Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.Thromb Haemost · 201570 citationsRCR 2.5
- 56 citationsRCR 2.4
- Improvements in Endovascular Treatment for Acute Ischemic Stroke: A Longitudinal Study in the MR CLEAN Registry.Stroke · 202246 citationsRCR 4.2
- Imagery rescripting and eye movement desensitisation and reprocessing for treatment of adults with childhood trauma-related post-traumatic stress disorder: IREM study design.BMC Psychiatry · 201723 citationsRCR 1.4